Long-term safety of drug-eluting stents in patients on warfarin treatment

References

• Helft G, Gilard M, Le Feuvre C, Zaman AG. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Nat Clin Pract Cardiovasc Med. 2006;3:673–80.
   PubMedGoogle Scholar
• Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet. 2004;364: 583–91.
   PubMed Web of Science ®Google Scholar
• Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, . Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med. 2007;356: 998–1008.
   PubMed Web of Science ®Google Scholar
• Bavry AA, Kumbhani DJ, Helton TJ, Bhatt DL. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? J Am Coll Cardiol. 2005;45:941–6.
   PubMed Web of Science ®Google Scholar
• Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, . Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–30.
   PubMed Web of Science ®Google Scholar
• Karjalainen PP, Porela P, Ylitalo A, Vikman S, Nyman K, Vaittinen MA, . Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting. Eur Heart J. 2007;28:726–32.
   PubMed Web of Science ®Google Scholar
• Rubboli A, Halperin JL, Airaksinen KE, Buerke M, Eeckhout E, Freedman SB, . Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med. 2008;40:428–36.
   PubMed Web of Science ®Google Scholar
• Gilard M, Blanchard D, Helft G, Carrier D, Eltchaninoff H, Belle L, . Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). Am J Cardiol. 2009;104:338–42.
   PubMed Web of Science ®Google Scholar
• Lip GY, Huber K, Andreotti F, Arnesen H, Airaksinen KJ, Cuisset T, . Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting. Thromb Haemost. 2010;103:13–28.
   PubMed Web of Science ®Google Scholar
• Airaksinen KEJ, Ylitalo A, Karjalainen PP. Drug-eluting stents in patients on long-term oral anticoagulation therapy: a mission impossible? Interv Cardiol. 2010;2:127–35.
   Google Scholar
• Karjalainen PP, Vikman S, Niemela M, Porela P, Ylitalo A, Vaittinen MA, . Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J. 2008;29:1001–10.
   PubMed Web of Science ®Google Scholar
• Korkeila P, Ylitalo A, Koistinen J, Airaksinen KEJ. Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: A prospective serial venographic study. Ann Med. 2009;41:216–23.
   PubMed Web of Science ®Google Scholar
• Annala A-P, Karjalainen PP, Porela P, Nyman K, Ylitalo A, Airaksinen KEJ. Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment. Am J Cardiol. 2008;102:386–90.
   PubMed Web of Science ®Google Scholar
• Korkeila P, Mustonen P, Koistinen J, Nyman K, Ylitalo A, Karjalainen P, . Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study. Europace. 2010;12:817–24.
   Web of Science ®Google Scholar
• Lahtela H, Karjalainen PP, Niemelä M, Vikman S, Kervinen K, Ylitalo A, . Are glycoprotein inhibitors safe during percutaneous coronary intervention in patients on chronic warfarin treatment? Thromb Haemost. 2009;102:1227–33.
   PubMed Web of Science ®Google Scholar
• Airaksinen KE, Suurmunne H, Porela P, Niemelä M, Vikman S, Puurunen M, . Usefulness of outpatient bleeding risk index to predict bleeding complications in patients with long-term oral anticoagulation undergoing coronary stenting. Am J Cardiol. 2010;106:175–9.
   PubMed Web of Science ®Google Scholar
• Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke. Results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864–70.
   PubMed Web of Science ®Google Scholar
• Beyth R, Quinn L, Landefeld C. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med. 1998;105:91–9.
   PubMed Web of Science ®Google Scholar
• Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med. 1998;338:1488–97.
   PubMedGoogle Scholar
• Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, . Clinical end points in coronary stent trials. A case for standardized definitions. Circulation. 2007;115: 2344–51.
   PubMed Web of Science ®Google Scholar
• Rogacka R, Chieffo A, Michev I, Airoldi F, Latib A, Cosgrave J, . Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral antiocoagulation. J Am Coll Cardiol Interv. 2008;1:56–61.
   Google Scholar
• Ruiz-Nodar JM, Marín F, Sánchez-Payá J, Hurtado JA, Valencia-Martín J, Manzano-Fernándes S, . Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. Eur Heart J. 2009;30:932–9.
   PubMed Web of Science ®Google Scholar
• Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, . Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation. 2009; 119:1873–82.
   PubMed Web of Science ®Google Scholar
• Rossini R, Musumeci G, Lettieri C, Molfese M, Mihalcsik L, Mantovani P, . Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy. Am J Cardiol. 2008;102: 1618–23.
   PubMed Web of Science ®Google Scholar
• Sarafoff N, Ndrepepa G, Mehilli J, Dörrler K, Schulz S, Lijima R, . Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med. 2008;264:472–80.
   PubMed Web of Science ®Google Scholar
• Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, . The primary and secondary prevention of coronary artery disease. Chest. 2008;133: 776S–814S.
   PubMed Web of Science ®Google Scholar
• Holmes DR Jr, Kereiakes DJ, Kleiman NS, Moliterno DJ, Patti G, Grines CL. Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol. 2009;54:95–109.
   PubMed Web of Science ®Google Scholar